TCL Archive Congress Mandates NIH Cut PR Costs, Coordinate Spending on Communications By Cancer History Project January 31, 2014
TCL Archive Abraxane-Gemcitabine Combination Extends Overall Survival in Phase III Trial By Cancer History Project January 31, 2014
TCL Archive IPRI’s Peter Boyle on Closing the Gap In Global Cancer Treatment And Outcomes By Cancer History Project January 31, 2014
TCL Archive Phase III Trial of Imbruvica Halted, Following Increases in Progression-Free Survival By Cancer History Project January 31, 2014
TCL Archive President Calls For Reversing Cuts to Basic Research Budget By Cancer History Project January 31, 2014
TCL Archive Long-term Follow-up Shows ADH and ALH Tissue Abnormalities Can Carry Similar Risk By Cancer History Project January 31, 2014
TCL Archive Drasga, Einhorn Make Appeal For Single-Payer Healthcare By Cancer History Project January 31, 2014
TCL Archive Patients on Hypertension Meds Lived Longer, Analysis Shows By Cancer History Project January 31, 2014
Primary SourceSpotlight Article Iressa: Oncologic Drugs Advisory Committee Meeting Sept. 24, 2002 By FDA Oncology Center of Excellence
Primary SourceSpotlight Article Waun Ki Hong, M.D. Oral History Interview, 2013 By MD Anderson Cancer Center